Final - June 23, 2011 

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
 

Centers for Disease Control and Prevention
 

1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Atlanta, Georgia
 

June 22-23, 2011 

AGENDA ITEM
 

Wednesday, June 22, 2011
 

8:00 Welcome & Introductions 

8:30 Herpes Zoster Vaccine 

· Introduction 

· Discussion 

· Licensure of Zostavax for adults of ages 50-59 

· Merck vaccine supply status and projections 

10:00 Varicella 

· Update on varicella epidemiology since implementation of 

routine 2-dose varicella vaccination for children 

10:15 Break 

10:45 Meningococcal Vaccine 

· Introduction 

· Menactra indication for a two dose series in 9 and 12 month olds 

· Recommendations for infants at increased risk for 

meningococcal disease 

· Vaccines for Children (VFC) program vote 

· MenAfriVacTM (meningococcal A conjugate vaccine) introduction 

in Burkina Faso 

11:40 MMR Vaccine Work Group Update 

· Introduction
 

· 2011 measles epidemiology update (U.S.)
 

12:00 Lunch 

1:00 Pertussis 

· Introduction 

· Safety of maternal vaccination to mother and fetus 

· Decision and cost-effectiveness analysis: maternal vaccination 

and cocooning 

· "Cocooning" 

· Timing of maternal vaccination: pregnancy or post-partum? 

· Proposed recommendations on maternal Tdap vaccination 

· Proposed recommendation on use of Tdap for contacts of 

newborns ("cocooning") and special situations 

· Tdap in pregnant and post-partum women through age 18 years 

· Emergence of pertussis in children aged 7 through 10 years and 

early evaluation of DTaP effectiveness in California 

2:45 Vaccine Supply 

3:00 Break 

3:30 Human Papillomavirus Vaccines 

· Introduction
 

· Background
 

· Quadrivalent HPV vaccine: duration of protection
 

· HPV-associated oropharyngeal cancer
 

· Cost effectiveness issues for male vaccination
 

· Policy considerations - HPV vaccine for males
 

5:00 Public Comment 

5:15 Adjourn 

PURPOSE 

Information & 

Discussion 

Information 

Information
 

Discussion &
 

Vote
 

Vote
 

Information 

Information 

Vote 

Vote 

VFC Vote 

Information &
 

Discussion
 

Information
 

Information &
 

Discussion
 

PRESIDER/PRESENTER(s) 

Dr. Carol Baker (ACIP Chair)
 

Dr. Larry Pickering (ACIP Executive Secretary; CDC)
 

Dr. Paul Cieslak (ACIP, WG Chair)
 

Dr. Eddy Bresnitz and Mr. Jim Robinson (Merck)
 

Dr. Rafael Harpaz (CDC/NCIRD)
 

Dr. Stephanie Bialek (CDC/NCIRD)
 

Dr. Cody Meissner (ACIP, WG Chair)

Dr. David Johnson (Sanofi) 

Dr. Amanda Cohn (CDC/NCIRD) 

Dr. Lance Rodewald (CDC/NCIRD) 

Dr. Thomas Clark (CDC/NCIRD) 

Dr. Jon Temte (ACIP, WG Chair)
 

Dr. Huong McLean (CDC/NCIRD)
 

Dr. Mark Sawyer (ACIP, WG Chair)
 

Dr. Sonja Rasmussen (CDC/OID)
 

Dr. Garrett Asay (CDC/NCIRD)
 

Dr. Jennifer Liang (CDC/NCIRD)
 

Dr. Jennifer Liang (CDC/NCIRD)
 

Dr. Jennifer Liang (CDC/NCIRD)
 

Dr. Jennifer Liang (CDC/NCIRD)
 

Dr. Lance Rodewald (CDC/NCIRD)
 

Dr. Lara Misegades (CDC/NCIRD)
 

Dr. Lance Rodewald (CDC/NCIRD)
 

Dr. Janet Englund (ACIP, WG Chair)
 

Dr. Lauri Markowitz (CDC/NCHHSTP)
 

Dr. Alfred Saah (Merck)
 

Dr. Aimee Kreimer (NCI) 

Dr. Harrell Chesson (CDC/NCHHSTP)
 

Dr. Eileen Dunne (CDC/NCHHSTP)
 

page 1 of 2 
 

 

 

 

 

 

 

Final - June 23, 2011 

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
 

Centers for Disease Control and Prevention
 

1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Atlanta, Georgia
 

June 22-23, 2011 

AGENDA ITEM PURPOSE 

Thursday, June 23, 2011 

8:00 Unfinished Business 

8:15 Agency Updates 

CDC, CMS, DoD, DVA, FDA, HRSA, IHS, NVPO, NIH Information 

8:30 General Recommendations: Febrile Seizures 

· Introduction 

· Clinical aspects of febrile seizures 

· Safety data update 

· Burden of disease information; next steps 

Information 

Discussion 

9:45 Break 

10:15 Hepatitis B Vaccine 

· Introduction 

· Update of hepatitis B incidence among persons with diabetes 

· Cost effectiveness of hepatitis B vaccination among persons with 

diabetes 

· Next steps 

Information & 

Discussion 

11:15 13-valent Pneumococcal Conjugate Vaccine (PCV13) 

· Introduction 

· Public health and economic impact of PCV13 in US adults ≥50 

years of age 

· Current epidemiology of pneumococcal disease in adults 

· Considerations for PCV13 use among adults; summary of 

immunogenicity and efficacy; cost-effectiveness studies 

Information & 

Discussion 

12:35 Lunch 

1:45 Influenza 

· Introduction 

· Influenza vaccine and egg allergies 

· Proposed recommendations 

· Intradermal influenza vaccine 

· Fluzone High Dose update 

Information 

Vote 

Information & 

& Discussion 

3:05 Public Comment 

3:20 Adjourn 

Acronyms 

DTaP Diphtheria, Tetanus, and Acellular Pertussis Vaccine 

NCCDPHP National Center for Chronic Disease Prevention and Health Promotion 

NCEZID National Center for Emerging and Zoonotic Infectious Diseases 

NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention 

NCI National Cancer Institute 

NCIRD National Center for Immunization and Respiratory Diseases 

OID Office of Infectious Diseases 

RTI Research Triangle International 

SHEA Society for Healthcare Epidemiology of America 

TBD To be determined 

Tdap Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 

WG Work Group 

PRESIDER/PRESENTER(s) 

Dr. Carol Baker (Chair, ACIP) 

Ex officio members 

Dr. Jeff Duchin (ACIP, WG Chair)
 

Dr. Harry Keyserling (WG Member, SHEA; Emory
 

University School of Medicine)
 

Dr. Jerome Tokars (CDC/NCEZID)
 

Dr. Andrew Kroger (CDC/NCIRD)
 

Dr. Mark Sawyer (ACIP, WG Chair)
 

Ms. Meredith Reilly (CDC/NCHHSTP)
 

Dr. Tom Hoerger (RTI International)
 

Dr. Trudy Murphy (CDC/NCHHSTP)
 

Dr. Mike Marcy (ACIP, WG Chair)
 

Dr. David Strutton (Pfizer)
 

Dr. Tamara Pilishvilli (CDC/NCIRD)
 

Dr. Tamara Pilishvilli (CDC/NCIRD)
 

Dr. Wendy Keitel (ACIP, WG Chair)
 

Dr. John Kelso (Scripps Clinic, University of 

California, San Diego); Dr. Matthew Greenhawt 

(University of Michigan Medical School, Ann Arbor); 

Dr. Matthew Fenton (NIAID, NIH)
 

Dr. Lisa Grohskopf (CDC/NCIRD)
 

Dr. David Johnson (sanofi pasteur)
 

Dr. David Johnson (sanofi pasteur); Dr. Pedro Moro
 

(CDC/NCEZID)
 

This document can be found on the CDC website at: http://www.cdc.gov/vaccines/recs/acip/downloads/agenda-jun11.pdf page 2 of 2